Adoption of Regulations for Cell Therapy Development: Linkage Between Taiwan and Japan

Teng Huang Tsai, Thai Yen Ling, Chung Hsi Lee

研究成果: 雜誌貢獻回顧型文獻同行評審

摘要

Although cell-based therapy has become a promising treatment, its practice and evaluation process remain unstandardized. Therefore, Japan initiated a dual-track regulatory framework for cell-based therapy aiming to promote and regulate the therapies to ensure that patients can access safe and effective treatments. Influenced by such pathway, Taiwan adopted the framework and initiated its own cell-based therapy regulation in 2018. This paper discusses how Japan has influenced Taiwan in developing regulations for cell-based therapy.

原文英語
頁(從 - 到)1045-1047
頁數3
期刊Clinical and Translational Science
13
發行號6
DOIs
出版狀態已發佈 - 十一月 2020

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

指紋 深入研究「Adoption of Regulations for Cell Therapy Development: Linkage Between Taiwan and Japan」主題。共同形成了獨特的指紋。

引用此